Structure (Pravastatin Tabs 8539 8540 8541 8542 1)
Pravastatin Sodium Tablet
Product Images NDC 0615-8539
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pravastatin Sodium (NDC 0615-8539). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Pravastatin Tabs 8539 8540 8541 8542 2)
This text provides crucial information on the survival distributions of subjects without event (coronary heart disease death or nonfatal myocardial infarction) over five years since randomization. The logrank test results show a statistically significant difference between the placebo and pravastatin groups (P=0.0001), suggesting a potential impact of pravastatin on reducing the occurrence of cardiovascular events.*
Principal Display Panel (Pravastatin Tabs 8539 8540 8541 8542 3)
This text contains information related to Pravastatin Sodium tablets, USP 10 mg. It includes details such as the lot number, packaging details, manufacturer (Glenmark for Cipla), and storage instructions. The tablets are intended for institutional use only, and the usual dosage information is suggested to be checked in the package insert or full prescribing information. The manufacturing locations mentioned include Glasgow, KY.*
Principal Display Panel (Pravastatin Tabs 8539 8540 8541 8542 4)
This text provides information on Pravastatin Sodium tablets with a strength of 20 mg per tablet. It includes details about the manufacturer, packaging, lot numbers, storage conditions, and dosage instructions. The tablets contain Pravastatin sodium, USP, and are for institutional use only. The text also mentions to store the tablets at 20°C to 25°C (68°F to 77°F) with permitted excursions to 15°C to 30°C (59°F to 86°F). The instruction is to keep them tightly closed, protected from moisture and light. The text advises referring to the package insert for full prescribing information.*
Principal Display Panel (Pravastatin Tabs 8539 8540 8541 8542 5)
This is information regarding Pravastatin Sodium tablets, each containing 40 mg of the active ingredient. The tablets are stored at a temperature range of 20°C to 25°C, with excursions permitted to 15°C to 30°C. The usual dosage should be followed as per the package insert. These tablets are manufactured by Glenmark for Vanguard Labs. The package includes different lots of tablets under the same formulation, denoted by LOT numbers. This medication is intended for institutional use only.*
Principal Display Panel (Pravastatin Tabs 8539 8540 8541 8542 6)
The text provided contains information about Pravastatin Sodium tablets in 80mg strength. It includes details such as manufacturing companies (Cipla and Glenmark), lot numbers, storage instructions, and the fact that it is for institutional use only. Please note that the actual content or dosage information is not clearly available due to the formatting of the text.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
